Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Total Liabilities came in at $220.2 million in Q2 2026, up 2.47% year-over-year from $214.9 million in Q2 2025, and down 1.21% quarter-over-quarter from $222.9 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Total Liabilities for 17 consecutive years, with $220.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities rose 2.47% year-over-year to $220.2 million in Q2 2026; TTM through Jun 2026 was $220.2 million, a 2.47% increase from a year earlier, with the FY2025 full-year figure at $222.2 million, up 3.56% from the prior year.
- Total Liabilities was $220.2 million for Q2 2026 at Lemaitre Vascular, down from $222.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $222.9 million in Q1 2026 and troughed at $34.7 million in Q1 2022.
- A 5-year average of $110.8 million and a median of $45.7 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities slumped 50.37% in 2022 and soared 393.5% in 2025, its largest moves.
- Over 5 years, Total Liabilities stood at $42.3 million in 2022, then climbed by 15.62% to $48.9 million in 2023, then surged by 338.9% to $214.5 million in 2024, then rose by 3.56% to $222.2 million in 2025, then dropped by 0.89% to $220.2 million in 2026.
- The last three Total Liabilities figures came in at $220.2 million (Q2 2026), $222.9 million (Q1 2026), and $222.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 57.45 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 2.58 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 42.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.94 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 20.04 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 3.14 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 9.50 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.83 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 220.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 220.21 Mn |
| Mar 31, 2026 | 222.90 Mn |
| Dec 31, 2025 | 222.17 Mn |
| Sep 30, 2025 | 219.15 Mn |
| Jun 30, 2025 | 214.91 Mn |
| Mar 31, 2025 | 208.43 Mn |
| Dec 31, 2024 | 214.53 Mn |
| Sep 30, 2024 | 45.95 Mn |
| Jun 30, 2024 | 43.55 Mn |
| Mar 31, 2024 | 45.45 Mn |
| Dec 31, 2023 | 48.88 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 42.64 Mn |
| Mar 31, 2023 | 40.70 Mn |
| Dec 31, 2022 | 42.28 Mn |
| Sep 30, 2022 | 40.80 Mn |
| Jun 30, 2022 | 41.39 Mn |
| Mar 31, 2022 | 34.67 Mn |
| Dec 31, 2021 | 38.65 Mn |
| Sep 30, 2021 | 40.43 Mn |